[CTXR] QoQ Quarter Result on 30-Sep-2022 [#Q4]

Stock
[CTXR] Citius Pharmaceuticals, Inc.
Announcement Date
22-Dec-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q4]
Profit Trend
QoQ- 9.31%
YoY- -61.08%
Quarter Report
CTXR's Result
CTXR's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -8,335 -10,382 -3,450 -7,415 -8,864 -7,561 -9,225 -6.55%
Tax 144 144 144 576 -53 -30 34 162.46%
NP -8,479 -10,526 -3,594 -7,991 -8,811 -7,531 -9,225 -5.48%
Tax Rate - - - - - - - -
Total Cost 8,479 10,526 3,594 7,991 8,811 7,531 9,225 -5.48%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -0.06 -0.07 -0.02 -0.05 -0.06 -0.05 -0.06 0.00%
EPS Diluted -0.06 -0.07 -0.02 -0.05 -0.06 -0.05 -0.06 0.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.